Allstate Corporation’s QuidelOrtho QDEL Stock Holding History

Allstate Corporation’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,230	Closed	-$530K	–	1415
2026 Q1	$530K	Buy	+32,230	New	+$792K	0.01%	994

Other funds holding QDEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allstate Corporation's QDEL Position: Q2 2026 in Review

Allstate Corporation sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 32,230 shares — an estimated $530K sold.

Allstate Corporation first reported a position in QDEL in Q1 2026 and held it in 1 quarter. The position peaked at $530K in Q1 2026. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

Allstate Corporation reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
Allstate Corporation sold 32,230 QuidelOrtho shares in Q2 2026, an estimated $530K.
Allstate Corporation first reported a position in QuidelOrtho in Q1 2026 and held it in 1 quarter.
Allstate Corporation's QuidelOrtho position peaked at $530K in Q1 2026.
245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.